Search Results 371-380 of 31282 for Ovary
Ovarian cancer is the most common cause of death from gynecological cancers in the U.S.. In their study, Dr. Goode and her collaborators showed that variations ...
This study is a double-blind, randomized, placebo-controlled (2:1 niraparib:placebo) study in patients with Stage III or IV ovarian cancer. Patients must have ...
This pilot, phase II trial studies how well everolimus and letrozole work in treating patients with hormone receptor positive ovarian, fallopian tube, or ...
Diabetic patients with ovarian cancer who took the drug metformin for their diabetes had a better survival rate than patients who did not take it. image of ...
Ovarian cancer remains a very deadly disease in part because it's often diagnosed at later stages. If the cancer has spread, it's even harder to treat. But ...
Mayo scientists explore swabs for early endometrial, ovarian cancer detection featured image. Individualized Medicine. Mayo scientists explore swabs for early ...
Peritoneal carcinomatosis usually comes from cancers that start in other organs, such as the colon, stomach or ovaries. ... Ovarian cancer. Colon or rectal ...
This phase II trial studies how well temsirolimus and bevacizumab work in treating patients with advanced endometrial, ovarian, liver, carcinoid, or islet cell ...
Lower risk of cancer of the ovaries and the lining of the uterus, ectopic pregnancy, ovarian cysts, and noncancerous breast disease · Improvement in acne and ...
Giving ribociclib together with letrozole may be an effective treatment in patients with ovarian, fallopian tube, primary peritoneal, or endometrial cancer.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.